Vitamin B6 and hemodialysis: The impact of high-flux high-efficiency dialysis and review of the literature

被引:49
作者
Kasama, R
Koch, T
CanalsNavas, C
Pitone, JM
机构
[1] Department of Medicine, School of Osteopathic Medicine, UMDNJ, Stratford, NJ 08084-1504
关键词
high-efficiency dialysis; water-soluble vitamins; vitamin B6; cuprophan; cellulose triacetate; pyridoxal-5'-phosphate;
D O I
10.1016/S0272-6386(96)90103-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
High-flux/high-efficiency (HF/HE) dialysis is associated with improved clearance for larger molecules, which include a wide variety of middle molecules and water-soluble vitamins, Our study attempted to measure in vivo clearances of serum pyridoxal-5'-phosphate (PLP), the active metabolite of vitamin De, on standard cuprophan versus cellulose triacetate HF/HE dialysis for patients maintained on 10 mg daily pyridoxine supplements, A longitudinal evaluation of PLP after 3 months on HF/HE dialysis was performed simultaneously, The average in vivo PLP clearance for six patients on standard hemodialysis increased by more than 50%, from 86 +/- 61.7 mL/min using a cuprophan membrane to 173 +/- 90.2 mL/min using a cellulose triacetate dialyzer, at average blood flows of 375 mL/min (P < 0.05), Levels of PLP decreased from a baseline of 50 +/- 13.8 ng/mL to 24 +/- 9.7 ng/mL (P < 0.05) after 3 months of HF/HE treatments; the levels returned to 45 +/- 6.4 ng/mL on resumption of standard dialysis treatments, Although not achieving statistical significance, the average hematocrit increased from 31.2% +/- 1.66% to 32.7% +/- 1.24% while on HF/HE dialysis without an increase in erythropoietin requirements, We conclude that HF/HE dialysis treatments can have a dramatic impact on vitamin B6 homeostasis. Further investigation to evaluate the effects of different membranes and reprocessing should be performed on more heterogeneous patient populations in whom compliance problems with diet and vitamin supplementation may exist, The increased clearance of vitamin as may have significantly more detrimental effects in these settings. (C) 1996 by the National Kidney Foundation, Inc.
引用
收藏
页码:680 / 686
页数:7
相关论文
共 17 条
[1]  
ALLMAN MA, 1992, EUR J CLIN NUTR, V46, P679
[2]  
BITSCH R, 1993, INT J VITAM NUTR RES, V63, P278
[3]   WATER-SOLUBLE VITAMINS IN CHRONIC-HEMODIALYSIS PATIENTS AND NEED FOR SUPPLEMENTATION [J].
DESCOMBES, E ;
HANCK, AB ;
FELLAY, G .
KIDNEY INTERNATIONAL, 1993, 43 (06) :1319-1328
[4]   A MECHANISTIC ANALYSIS OF THE NATIONAL COOPERATIVE DIALYSIS STUDY (NCDS) [J].
GOTCH, FA ;
SARGENT, JA .
KIDNEY INTERNATIONAL, 1985, 28 (03) :526-534
[5]   VITAMIN-B6 STATUS IN UREMIA [J].
GUZMAN, FJL ;
GONZALEZBUITRAGO, JM ;
VELA, R ;
CAVA, F ;
DECASTRO, S .
KLINISCHE WOCHENSCHRIFT, 1990, 68 (03) :183-186
[6]   DAILY REQUIREMENT FOR PYRIDOXINE SUPPLEMENTS IN CHRONIC-RENAL-FAILURE [J].
KOPPLE, JD ;
MERCURIO, K ;
BLUMENKRANTZ, MJ ;
JONES, MR ;
TALLOS, J ;
ROBERTS, C ;
CARD, B ;
SALTZMAN, R ;
CASCIATO, DA ;
SWENDSEID, ME .
KIDNEY INTERNATIONAL, 1981, 19 (05) :694-704
[7]   PYRIDOXAL 5'-PHOSPHATE DEFICIENCY IN UREMIC UNDIALYZED, HEMODIALYZED, AND NON-UREMIC KIDNEY-TRANSPLANT PATIENTS [J].
LACOUR, B ;
PARRY, C ;
DRUEKE, T ;
TOUAM, M ;
KREIS, H ;
BAILLY, M ;
DURAND, D .
CLINICA CHIMICA ACTA, 1983, 127 (02) :205-215
[8]  
Makoff R., 1991, J REN NUTR, V1, P56, DOI DOI 10.1016/S1051-2276(12)80195-6
[9]   DERANGED CONCENTRATIONS OF WATER-SOLUBLE VITAMINS IN THE BLOOD OF UNDIALYZED AND DIALYZED PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
MARUMO, F ;
KAMATA, K ;
OKUBO, M .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1986, 9 (01) :17-24
[10]   ERYTHROCYTE VITAMINS B1, B2 AND B6 AND ERYTHROPOIETIN [J].
MYDLIK, M ;
DERZSIOVA, K .
AMERICAN JOURNAL OF NEPHROLOGY, 1993, 13 (06) :464-466